Results from better quality studies should in some sense be more valid or more accurate than results from other studies, and as a consequence should tend to be distributed differently from results of other studies. To date, however, quality scores have been poor predictors of study results. We discuss possible reasons and remedies for this problem. It appears that 'quality' (whatever leads to more valid results) is of fairly high dimension and possibly non-additive and nonlinear, and that quality dimensions are highly application-specific and hard to measure from published information. Unfortunately, quality scores are often used to contrast, model, or modify meta-analysis results without regard to the aforementioned problems, as when used to directly modify weights or contributions of individual studies in an ad hoc manner. Even if quality would be captured in one dimension, use of quality scores in summarization weights would produce biased estimates of effect. Only if this bias were more than offset by variance reduction would such use be justified. From this perspective, quality weighting should be evaluated against formal bias-variance trade-off methods such as hierarchical (random-coefficient) meta-regression. Because it is unlikely that a low-dimensional appraisal will ever be adequate (especially over different applications), we argue that response-surface estimation based on quality items is preferable to quality weighting. Quality scores may be useful in the second stage of a hierarchical response-surface model, but only if the scores are reconstructed to maximize their correlation with bias.
INTRODUCTION
A common objection to meta-analytic summaries is that they combine results from studies of disparate quality. 'Study quality' is not given formal definition in the literature, but 'quality appraisals' usually involve classifying the study according to a number of traits or items that are reported in or determinable from the published paper. These traits are presumed to predict the accuracy of study results, where 'accuracy' is a function of both systematic and random error (Rothman and Greenland, 1998) . Often, * To whom correspondence should be addressed c Oxford University Press (2001) each of these quality items is assigned a number of points based on the a priori judgment of clinical investigators, then summed into a 'quality score' that purports to capture the essential features of the multidimensional quality space (Chalmers et al., 1981) . This score is then used as a weighting factor in averaging across studies (Fleiss and Gross, 1991; Bérard and Bravo, 1998; Moher et al., 1998) , or used as a covariate for stratifying or predicting study results.
Despite scientific objections to amalgamating quality items into a univariate score (Greenland, 1994a,b) , and empirical findings of deficiencies in such scores (Emerson et al., 1990; Juni et al., 1999) , quality scoring and weighting remains common in meta-analysis (Cho and Bero, 1994; Moher et al., 1995 Moher et al., , 1998 . Rigorous justifications for the weighting by quality scores are lacking or in error (Detsky et al., 1992; Greenland, 1994a,b) . Moher et al. (1998) claimed that weighting by quality scores resulted in the least statistical heterogeneity, but the measure of heterogeneity used (deviance) was arbitrarily multiplied by the quality weights; for instance, if the quality scores were all equal to 0.5, the pooled estimate would not change but this new measure of heterogeneity would drop by 50%! Given the lack of valid justification for quality weighting, it is worrisome that some statisticians as well as clinicians continue to use and even promote such scores, even though alternatives have long been available; for example, a weighting scheme based on precision and on magnitude of bias was proposed by Cox (1982) .
We will show that, in general, quality-score weighting methods produce biased effect estimates. This is so even when their component quality items capture all traits contributing to bias in study-specific estimates. Furthermore, one cannot rationalize this bias as being a worthwhile trade-off against variance without assessment of its size and its performance against other methods. We argue that quality-score weighting methods need to be replaced by direct modeling of quality dimensions, in part because the best estimate may not be any weighted average of study results. As an alternative to current uses of quality scores we propose mixed-effects (hierarchical) regression analysis of quality items with a summary quality score in the second stage. For this to work well the quality score needs to be constructed to maximize its correlation with bias.
A FORMAL EVALUATION OF QUALITY SCORING
The following evaluation is based on a response-surface model for meta-analysis (Rubin, 1990) . The model posits that the expected study-specific effect estimate is a function of the true effect in the study, plus bias terms that are functions of quality items. To illustrate, let i = 1, . . . , I index studies, and let X be a row vector of J quality items; for example, X could contain indicators of study design such as use of blinding (of patients, of treatment administration, of outcome evaluation) in meta-analyses of randomized trials, or type of sampling (cohort, case-control, cross-sectional) in meta-analyses of observational studies. Also define δ i = expected study-specific effect estimate, θ i = true effect of study treatment, x i = value of X for study i. The study-specific estimateδ i is usually the observed difference in an outcome measure among treated and untreated groups in study i, such as a difference in means, proportions, or log odds (in the latter case the expectations and biases discussed here are asymptotic);δ i may also be a fitted coefficient from a regression of outcome on treatment type. In contrast, θ i represents the object of inquiry, the actual impact of treatment on the outcome measure (Rubin, 1990; Vanhonacker, 1996) . Let x 0 be the value of X that is a priori taken to represent the 'best quality' with respect to the measured quality items. The response-surface approach models δ i as a regression function of θ i and x i . As a simple example, consider the additive model
where b i is the unknown bias produced by deviation of x i from the ideal x 0 . A common (implicit) assumption in quality scoring is that this ideal value is specified accurately, in the sense that there would be no bias contributed by measured quality items in a study with the ideal value x 0 . While this assumption may be reasonable, there will still be the bias component γ i of δ i that is due to other, unmeasured quality items. Model 1 has 3I parameters; because there are only I observationsδ 1 , . . . ,δ I , one needs some severe constraints to identify effects. Many analyses employ models in which neither b i nor γ i is present and in which the θ i are constrained to be either a constant θ or random effects drawn from a normal distribution with unknown mean and variance. These models have been criticized for ignoring known factors that lead to variation in the effects θ i across studies (heterogeneity of effects), such as differences in treatment protocols and subjects (e.g. differences in the age and sex composition of the study populations), as well as for ignoring known sources of bias and for increasing sensitivity of the analysis to publication bias (Cox, 1982, p. 48; L'Abbe et al., 1987, p. 231; Greenland, 1994a; Poole and Greenland, 1999) . Those critics advocate instead a 'meta-regression' approach to effect variation, in which measured study-specific covariates are used to model variation in θ i or δ i (e.g. Vanhonacker, 1996; Greenland, 1998) .
Although we agree with the aforementioned criticisms, there is some uncertainty fixed-effect summaries do not capture, and the addition of a fictional residual random effect to the model, however unreal, is often the only attempt made to capture that uncertainty. Hence, we begin by assuming that the θ i can be treated as random draws from a distribution with mean α and variance σ 2 , and that the γ i are zero (i.e. X captures all bias information), as do many authors (e.g. Bérard and Bravo, 1998) . With these assumptions, model 1 simplifies to
where
Here, α is the average effect of treatment in a hypothetical superpopulation of studies, of which the included studies are supposed to be a random sample. Under model 2, b i may be viewed as the perfect but unknown quality score, in that if it were known one could unbiasedly estimate α from the bias-adjusted estimatesδ i − b i , assuming that the random effects ε i and the sampling-error residualsδ i − δ i are uncorrelated. In the same manner, unbiased estimation of the b i would also suffice for unbiased estimation of α, assuming that errors in estimating b i are independent of other errors and of model parameters. Conversely, if the average study-specific bias was nonzero, information on the average b i would be necessary as well as sufficient for unbiased estimation of α under model 2.
Quality-scoring methods
Quality-scoring methods replace the vector of quality items X with a unidimensional scoring rule s(X ), where s(x) is a fixed function specified a priori that typically varies from 0 for a useless study to s(x 0 ) for a perfect one (e.g. 0-100%). Define s i = s(x i ) for i = 0, 1, . . . , I . The two main uses of the quality scores s i are Quality weighting: average the study-specific estimatesδ i after multiplying the usual inversevariance weight by a function of s i . For example, if v i = var(δ i |δ i ), the unconditional variance ofδ i is v i + σ 2 , the usual random-effects weight forδ i isŵ i = 1/(v i +σ 2 ), and the usual 'quality-adjusted' weight is s iŵi (Bérard and Bravo, 1998) . Quality-score stratification or regression: stratify or regress the estimatesδ i on the s i , then estimate α as the predicted value of δ at s 0 . For example, assuming bias to proportional to s 0 − s i , fit the submodel of model 2,
then takeα * , the predicted estimate for a perfect study, as the estimate of the average effect α.
A problem quality weighting shares with most weighting schemes is that it produces biased estimates, even if X contains all bias-related covariates (as in model 2) and our quality score is perfectly predictive of bias. To see this, let u i be any study-specific weight and let a subscript u denote averaging over studies using the u i as weights: for example,
Under model 2,
In words, δ u equals the u-average effect θ u plus the u-average bias b u . Thus, any unbiased estimator of δ u will be biased both for the conditional average effect θ u of the studies observed and for the superpopulation average effect α (unless of course no study is biased or there is a fortuitous cancellation of biases). This problem arises whether we use the usual estimator, for which
, or the qualityweighted estimator, for which u i = w i s i . The best one can do with quality weighting is reduce bias by shifting weight to less biased studies. Ordinarily, however, this shift would increase the variance of the weighted estimator, possibly not far enough to achieve the optimal bias-variance trade-off. To appreciate the issue here, if bias reduction were our only goal and the bias b i declined monotonically with increasing quality score s i , the minimum-bias estimator based on the scores would have weights u 1 = 1 for s i = max(s i ), 0 otherwise. In other words, if bias is all that matters and we trust our quality ranking, we should restrict our average solely to studies with the maximal score (even if there is only one such study) and throw out the rest (O'Rourke, 2001) . That this restriction is not made must reflect beliefs that there is useful information in studies of less-thanmaximal quality, and that some degree of bias is tolerable if it comes with a large variance reduction. This is a pragmatic viewpoint, especially if one considers the inevitable inaccuracies of any real score for bias prediction. It also recognizes that errors due to bias are not necessarily more costly than errors due to chance, and are certainly not infinitely more costly (as is implicitly assumed by limiting one's attention to unbiased estimators).
Under model 2, the quality-score regression estimatorα * from model 3 will incorporate a bias α * − α. This summary bias will be zero if the s 0 − s i are proportional to the true biases b i ; otherwise α * can easily be far from α, even if the scores are a monotone function of the bias b i and so properly rank the studies with respect to bias. As a simple numerical example, suppose the δ i are log relative risks; there is no true effect (θ i = α = ε i = 0), so δ i = b i ; that one-quarter of studies have s i = s 0 = 100, b i = 0; one-half have s i = 90, b i = ln(0.6); and that one-quarter have s i = 60, b i = ln(0.5). If v i is constant across studies, then (from a weighted least squares regression of δ i on s 0 − s i ) we get α * = −0.225, which results in a geometric mean relative risk from the quality regression of exp(α * ) = 0.80, rather than the true relative risk of 1.00.
PROBLEMS WITH QUALITY SCORES AS BIAS PREDICTORS
When a quality scoring rule contains many items irrelevant to bias (e.g. an indicator of whether power calculations were reported), these items will disproportionately reduce some of the resulting scores. Inclusion of such items can distort rankings as well. The bias α * − α can be viewed as arising from misspecification of the true bias function b(X ) by a one-parameter model [s 0 − s(X )]β * . Given the multidimensional nature of X , one should see that this surrogate involves an incredibly strict constraint on b(X ), with misspecification all but guaranteed.
The scoring rule s(X ) is usually a weighted sum Xq = j q j X j of the J quality items in X , where q is a column vector of 'quality weights' specified a priori. Inspection of common scoring rules reveals that the weights q j are fairly arbitrary item scores assigned by a few clinical experts, without reference to data on the relative importance of the items in determining bias. 'Score validations' are typically circular, in that the criteria for validation hinge on score agreement with opinions about which studies are 'high quality,' not on actual measurements of bias.
Perhaps the worst problem with common quality scores is that they fail to account for the direction of bias induced by quality deficiencies (Greenland, 1994b) . This failing can virtually nullify the value of a quality score in regression analyses. As a simple numerical example, suppose that trials are given 50 points out of 100 for having placebo controls and 50 points out of 100 for having validated outcome assessment, and that lack of outcome validation results in nondifferential misclassification. Suppose also that lack of placebo controls induces a bias in the risk difference of 0.1 (because then the placebo effect occurs only in the treated group), that lack of outcome validation induces a bias of −0.1 (because the resulting misclassification induces a bias towards the null), and that the biases are approximately additive. If n 1 studies lack placebo controls but have validated outcomes and n 2 lack validated outcomes but have placebo controls, the average biases among studies with quality scores of 0, 50, and 100 will be 0, (n 1 − n 2 )/(n 1 + n 2 ), and 0. Thus, the score will not even properly rank studies with respect to bias, even though it will properly rank studies with respect to number of deficiencies.
While the preceding example is grossly oversimplified, we think such bias cancellation phenomena are inevitable when quality scores are composed of many items combined without regard to bias direction (e.g. those in Cho and Bero (1994) or Moher et al. (1995) ). To avoid this problem, a quality score would have to be reconstructed as a bias score with signs attached to the contributing items. The resulting summary score should then be centered so that zero indicates no bias expected a priori, and values above and below zero should indicate relative amounts of expected positive and negative bias inδ i . Thus, if theδ i are log relative risks but expected biases are elicited on the relative-risk scale, the latter expectations must be translated to the log scale when constructing the quality scores.
BEYOND QUALITY SCORES
Expert opinions may be helpful determining items related to bias (i.e. what to include in X ), although some checklist items are indefensible (e.g. study power conveys no information beyond that in the variance v i , which is already used in the study weight). Expert opinions may even provide a rough idea of the rankings of the items in importance. Nonetheless, a more robust approach, one less dependent on the vagaries and prejudices of such opinions, would employ a more flexible surrogate for bias than that provided by quality scores.
Quality-item regression
If the number of quality items is not too large relative to the number and variety of studies in the metaanalysis (which may often be the case upon dropping items irrelevant to bias), one can fit a quality-item regression model, such as
where β † is a vector of unknown parameters. This approach is equivalent to treating the item weight vector q as an unknown parameter (with β * absorbed into q). Conversely, quality-score regression (model 3) is just a special case of model 6 with β † specified a priori up to an unknown scalar multiplier β * , as may be seen from
In other words, quality-score regression employs model 6 with a constraint β † = qβ * , with β * unknown. From a Bayesian perspective, this constraint is a 'dogmatic' prior distribution on β † that is concentrated entirely on the line qβ * in the J -dimensional parameter space for β † . Model 6 also corresponds to a J -parameter linear model for the bias function b(X ). Under model 2, the bias inherent in this assumption is α † − α. Because model 3 is a submodel of model 6, however, the bias α † − α will be no more than the bias α * − α inherent in the quality-score regression; on the other hand, the varianceα † may be much larger than that ofα * . This model may be extended further by specifying a second-stage model for λ † , so that λ † (like β † ) may have both fixed and random components.
All the models described above are special cases of mixed-effects meta-regression models described and studied by earlier authors (Cochran, 1937; Yates and Cochran, 1938; Cox, 1982; Raudenbush and Bryk, 1985; Stram, 1996; Platt et al., 1999) . From this perspective, common quality-score methods are not only biased; they also do not exploit the full flexibility of these models. This flexibility offers an alternative to the strict reliance an expert judgment inherent in common methods, and should be sufficient to justify a shift in current practice. There are several major obstacles to this shift, however. Among them are a general lack of familiarity with mixed models, especially in the 'semi-Bayesian' form that is arguably most useful in epidemiology and medical research (Greenland, 1993 (Greenland, , 2000 , and a lack of generalized-linear mixed modeling modules within most packages used by health researchers. We regard as unrealistic the response we commonly get from academic statisticians, to the effect that everyone should just be using BUGS or some such Markov chain Monte Carlo software; this response seems oblivious to the subtle specification and convergence issues that arise in such use. Much more transparent and stable methods are available, such as mixed modeling with data augmentation priors (Bedrick et al., 1996) , which can be implemented easily with ordinary regression software by adding 'prior data' to the data set (Greenland, 2001; Greenland and Christensen, 2001) . If necessary, one may use extensions of likelihood methods to model variation in heterogeneity (Smyth and Verbyla, 1999) .
Finally, we note that the overall validity of any meta-analysis is limited by the detail of information that can be obtained on included studies, and by the completeness of study ascertainment (Light and Pillemer, 1984; Begg and Berlin, 1988) . Such problems will be best addressed by improved editorial requirements for reporting (Meinert, 1998) and by efforts to identify all studies and enter them into accessible online registries.
